<?xml version="1.0" encoding="UTF-8"?>
<ref id="B44-vaccines-07-00045">
 <label>44.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ducatez</surname>
    <given-names>M.F.</given-names>
   </name>
   <name>
    <surname>Bahl</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Griffin</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Stigger-Rosser</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Franks</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Barman</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Vijaykrishna</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Webb</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Guan</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Webster</surname>
    <given-names>R.G.</given-names>
   </name>
  </person-group>
  <article-title>Feasibility of reconstructed ancestral H5N1 influenza viruses for cross-clade protective vaccine development</article-title>
  <source>Proc. Natl. Acad. Sci. USA</source>
  <year>2011</year>
  <volume>108</volume>
  <fpage>349</fpage>
  <lpage>354</lpage>
  <pub-id pub-id-type="doi">10.1073/pnas.1012457108</pub-id>
  <pub-id pub-id-type="pmid">21173241</pub-id>
 </element-citation>
</ref>
